In terms of BCR signaling responses, r-axSpA patients show similarities with SLE patients, where hyperactivated PI3K/Akt/mTOR signaling has been described in CD24-CD20hi B cells characterized by a CD27-CD21loCD11c+T-bet+ phenotype [38]. The gene discussed is MTOR; the disease is systemic lupus erythematosus.